Security Reports > Emergent BioSolutions

Emergent BioSolutions
Data Breaches, Cyber Attacks and Security Report

https://emergentbiosolutions.com  ᛫ 
Last updated July 12, 2020

Emergent BioSolutions Security Rating

${grade.letter}
${cstarScore}
/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Emergent BioSolutions is implementing good security practices.

Company Information

Company:
${companyName}
Valuation:
${marketCap}
Employees:
${employees}
Location:
${country}
CEO:
${ceo}

About Emergent BioSolutions

Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes. Among the company's notable products is BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA).


Data Breaches and Security News


Security Report for Emergent BioSolutions

Want a security rating for your organization?

This report shows a preliminary security rating for Emergent BioSolutions. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Emergent BioSolutions's security performance with other companies